Upcoming webinar
Thursday 3 December 2026 | 3pm GMT | 10am ET

Pharma’s Patient, Consumer Health’s Playbook: Capturing The Shared GLP-1 Opportunity

GLP-1s are still prescription medicines. But the way patients find, choose, access and stay on them is starting to look a lot like consumer health.

About

About this webinar

GLP-1s are driving business model innovation in pharma, making parts of the traditional Rx model look increasingly like consumer health. At the same time, consumer health companies see an opening to position their products as companions to GLP-1 treatment, supporting patients on their weight loss journeys.

In this Scrip and HBW Insight webinar, senior voices from pharma, consumer health and strategy consulting explore what each side can teach the other. You will leave with a clearer view of how the patient journey is being redrawn, where the strongest partnership opportunities sit, and what it takes to win and keep GLP-1 patients.

The session will answer:
  • Is direct-to-patient GLP-1 selling a pharma model with a new channel, or a consumer health model with a prescription attached?
  • What role can consumer health’s companion products play around GLP-1 treatment, from side effects to nutritional needs?
  • What does a winning consumer value proposition look like, and where does consumer health’s playbook help pharma differentiate beyond the molecule?
  • What can pharma learn from consumer health about orchestrating physicians, pharmacists and e-commerce to reach and keep patients?
  • Where could pharma and consumer health partner, and what would that look like in practice?
upcoming webinar
Dec 3 • Free • 45 mins
Join our panel for a candid conversation on the shared GLP-1 opportunity. The session is 45-minutes, free to attend, and includes access to the recording afterwards.
Experts

Speakers

Headshot of Melanie Raouzeos-Haid.

Melanie Raouzeos-Haid

CVP Medical and Marketing, Region Emerging Markets

View profile

Headshot of Andy Roberts.

Andy Roberts

SVP New Growth Platforms

View profile

Headshot of Christian Danelund.

Christian Ring Danelund

Senior Director

View profile

Headshot of Aakash Babu

Aakash Babu

Managing Editor

View profile

Headshot of Tom Gallen.

Tom Gallen

Managing Editor

View profile

FAQ

Frequently Asked Questions

GLP-1s remain prescription medicines, but patients now research, compare and buy treatment in ways that resemble consumer health. That creates openings for both sides: pharma can borrow consumer health’s strengths in brand building and omnichannel activation, while consumer health can reach a defined, health-engaged patient population.

The panel looks at direct-to-patient selling, companion products for side effects and nutritional needs, what makes a winning consumer proposition, omnichannel orchestration across physicians, pharmacists and e-commerce, and where partnership could work.
Anyone in pharma, consumer health, or the advisory and agency community who needs a clear view of how GLP-1 commercial models are evolving. That includes commercial, brand, marketing, digital, strategy and business development teams.
A practical view of what each side can learn from the other, the capabilities and partnership models that could speed up commercial success, and expert perspectives from Novo Nordisk, Bayer Consumer Health and Simon-Kucher & Partners.
Yes. Everyone who registers will receive the recording and materials after the event.
Register

Register for the webinar

Can’t make the live date? Register anyway and you’ll receive the recording once the event has taken place.

Choose a time to talk

専門家との相談日時を選択

Calendar requires cookies. Enable cookies

カレンダーの表示にはCookieの有効化が必要です Cookieを有効にする

Or send us a message and we'll be in touch

面談の有無がお決まりでない場合は、お問い合わせ内容をお送りください。担当者よりご連絡いたします。